To identify FXS-specific changes in human NPCs lacking FMRP, we compared the genome-wide gene expression of NPCs derived from three patient-specific FXS and three control male iPSC lines using high density oligonucleotide expression array. This evidence concerns the gene FMR1 and fragile X syndrome.